Acute exposure to low lead levels and its implications on the activity and expression of cytosolic thioredoxin reductase in the kidney

Basic and Clinical Pharmacology and Toxicology

Volumn 114, Issue 6, 2014, Pages 476-484

  Conterato, Greicy M M ^a   Quatrin, Andréia ^b   Somacal, Sabrina ^b   Ruviaro, Amanda R ^b   Vicentini, Juliana ^c   Augusti, Paula R ^d   Sobieski, Rocheli ^b   Figueiredo, Cassieli ^b   dos Santos, Clarissa M M ^b   Pereira, Talita C B ^e   Bogo, Maurício R ^e,f   Flores, Erico M M ^b   Emanuelli, Tatiana ^b  

^a Universidade Comunitaria Regional de Chapeco   (Brazil)

^b FEDERAL UNIVERSITY OF SANTA MARIA   (Brazil)

^c General Forensic Institute   (Brazil)

^d FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^e PONTIFICAL CATHOLIC UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^f National Institute of Science and Technology in Translational Medicine   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; LEAD; PORPHOBILINOGEN SYNTHASE; THIOREDOXIN REDUCTASE 1; KEAP1 PROTEIN, RAT; SIGNAL PEPTIDE; TXNRD1 PROTEIN, RAT;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOSOL; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; ERYTHROCYTE; EXPOSURE; GENE EXPRESSION; HISTOPATHOLOGY; KIDNEY INJURY; MALE; NEPHROTOXICITY; NONHUMAN; NUCLEOTIDE SEQUENCE; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; ANIMAL; DRUG EFFECTS; ENZYMOLOGY; GENETICS; KIDNEY; METABOLISM; PATHOLOGY; PHYSIOLOGY; TOXICITY; WISTAR RAT;

RATTUS;

ANIMALS; CYTOSOL; ERYTHROCYTES; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; KIDNEY; LEAD; MALE; PORPHOBILINOGEN SYNTHASE; RATS; RATS, WISTAR; THIOREDOXIN REDUCTASE 1;

EID: 84900012228     PISSN: 17427835     EISSN: 17427843     Source Type: Journal    
DOI: 10.1111/bcpt.12183     Document Type: Article

References (55)

1. Needleman H. Lead poisoning. Ann Rev Med 2004;55:209-22.
2. Agency for Toxic Substances and Disease Registry. Toxicological Profile for Lead. US Department of Health and Human Services, Public Health Service, Atlanta, GA, 2007.
3. Barbosa F Jr, Fillion M, Lemire M, Passos CJ, Rodrigues JL, Philibert A et al. Elevated blood lead levels in a riverside population in the Brazilian. Amazon Environ Res 2009;109:594-9.
4. Boraiko C, Wright EM, Ralston F. Lead contamination of paint remediation workers' vehicles. J Environ Health 2013;75:22-7.
5. Goyer RA. Mechanisms of lead and cadmium nephrotoxicity. Toxicol Lett 1989;46:153-62.
6. Garçon G, Leleu B, Marez T, Zerimech F, Haguenoer JM, Furon D et al. Biomonitoring of the adverse effects induced by the chronic exposure to lead and cadmium on kidney function: usefulness of alpha-glutathione S-transferase. Sci Total Environ 2007;377:165-72.
7. Campagna D, Huel G, Girard F, Sahuquillo J, Blot P. Environmental lead exposure and activity of delta-aminolevulinic acid dehydratase (ALA-D) in maternal and cord blood. Toxicology 1999;134:143-52.
8. Goering PL. Lead-protein interactions as a basis for lead toxicity. Neurotoxicology 1993;14:45-60.
9. Jurczuk M, Moniuszko-Jakoniuk J, Brzóska MM. Involvement of some low-molecular thiols in the peroxidative mechanisms of lead and ethanol action on rat liver and kidney. Toxicology 2006;219:11-21.
10. Monteiro HP, Abdalla DSP, Augusto O, Bechara EJ. Free radical generation during delta-aminolevulinic acid auto-oxidation: induction by hemoglobin and connections with porphyrinpathies. Arch Biochem Biophys 1989;271:206-16.
11. Conterato GMM, Augusti PR, Somacal S, Einsfeld L, Sobieski R, Torres JR et al. Effect of lead acetate on cytosolic thioredoxin reductase activity and oxidative stress parameters in rat kidneys. Basic Clin Pharmacol Toxicol 2007;101:96-100.
12. Conterato GMM, Bulcão RP, Sobieski R, Moro AM, Charão MF, Freitas FA et al. Blood thioredoxin reductase activity, oxidative stress and hematological parameters in painters and battery workers: relationship with lead and cadmium levels in blood. J Appl Toxicol 2013;33:142-50.
13. Patra RC, Swarup D, Dwivedi SK. Antioxidant effects of alpha tocopherol, ascorbic acid and L-methionine on lead induced oxidative stress to the liver, kidney and brain in rats. Toxicology 2001;162:81-8.
14. Nordberg J, Arnér EJS. Reactive oxygen species, antioxidants, and the mammalian thioredoxin system. Free Radic Biol Med 2001;31:1287-312.
15. Zhong L, Arner ES, Ljung J, Aslund F, Homgren A. Rat and calf thioredoxin reductase are homologous to glutathione reductase with a carboxyl-terminal elongation containing a conserved catalytically active penultimate selenocysteine residue. J Biol Chem 1998;273:8581-91.
16. Arner ES. Focus on mammalian thioredoxin reductases-important selenoproteins with versatile functions. Biochim Biophys Acta 2009;1790:495-526.
17. Chen Z-H, Saito Y, Yoshida Y, Sekine A, Noguchi N, Niki E. 4-Hydroxynonenal induces adaptive response and enhances PC12 cell tolerance primarily through induction of thioredoxin reductase 1 via activation of Nrf2. J Biol Chem 2005;280:41921-7.
18. Park YS, Misonou Y, Fujiwara N, Takahashi M, Miyamoto Y, Koh YH et al. Induction of thioredoxin reductase as an adaptive response to acrolein in human umbilical vein endothelial cells. Biochem Biophys Res Commun 2005;327:1058-65.
19. Sakurai A, Nishimoto N, Himeno S, Imura N, Tsujimoto M, Kunimoto M et al. Transcriptional regulation of thioredoxin reductase-1 expression by cadmium in vascular endothelial cells: role of NF-E2-related factor-2. J Cell Physiol 2005;203:529-37.
20. Wataha JC, Lewis JB, Mccloud VV, Shaw M, Omata Y, Lockwood PE et al. Effect of mercury (II) on Nrf2, thioredoxin reductase-1 and thioredoxin-1 in human monocytes. Dent Mater 2008;24:765-72.
21. Berlin A, Schaller KH. European standardized method for the determination of d-aminolevulinic acid dehydratase activity in blood. Z Klin Chem Klin Biochem 1974;12:389-90.
22. Sassa S. Delta-aminolevulinic acid dehydratase assay. Enzyme 1982;28:133-45.
23. Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 1979;95:351-8.
24. Levine R, Garland D, Oliver CN, Amici A, Climent I, Lenz AG et al. Determination of carbonyl content in oxidatively modified proteins. Methods Enzymol 1990;186:464-78.
25. Hill KE, Mccollum GW, Boeglin ME, Burk RF. Thioredoxin reductase is decreased by selenium deficiency. Biochem Biophys Res Commun 1997;234:293-5.
26. Holmgren A, Björnstedt M. Thioredoxin and thioredoxin reductase. Methods Enzymol 1995;252:199-208. doi:10.1016/0076-6879(95)52023-6.
27. Omata Y, Folan M, Shaw M, Messer RL, Lockwood PE, Hobbs D et al. Sublethal concentrations of diverse gold compounds inhibit mammalian cytosolic thioredoxin reductase (TrxR1). Toxicol In Vitro 2006;20:882-90.
28. Misra HP, Fridovich I. The role of superoxide anion in the autooxidation of epinephrine and a simple assay for superoxide dismutase. J Biol Chem 1972;247:3170-5.
29. Carlberg I, Mannervick B. Inhibition of glutathione reductase by interaction of 2, 4, 6- trinitrobenzenesulfonate with active-site dithiol. FEBS Lett 1977;98:263-6.
30. Lowry DH, Rosebrough NJ, Farr AL, Randall RF. Protein measurement with the folinphenol reagent. J Biol Chem 1951;193:265-75.
31. Tang R, Dodd A, Lai D, Mcnabb WC, Love DR. Validation of Zebrafish (Danio rerio) reference genes for quantitative real-time RT-PCR normalization. Acta Biochim Biophys Sin 2007;39:384-90.
32. Rho HW, Lee BC, Choi ES, Choi IJ, Lee YS, Goh SH. Identification of valid reference genes for gene expression studies of human stomach cancer by reverse transcription-qPCR. BMC Cancer 2010;10:1-13.
33. Erkhembayara S, Mollbrinka A, Erikssona M, Larsen EH, Eriksson LC. Selenium homeostasis and induction of thioredoxin reductase during long term selenite supplementation in the rat. Toxicology 2011;25:254-9.
34. Jugo S, Maljkovic T, Kostial K. The effect of chelating agents on lead excretion in rats in relation to age. Environ Res 1975;10:271-9.
35. Jugo S, Kello D. Resorption of lead compounds from the peritoneal cavity in rats. Health Phys 1975;28:617-18.
36. World Health Organization. Inorganic Lead. International Programme on Chemical Safety. Environmental Health Criteria series 165. WHO, Geneva, 1995.
37. Graziano JH. Validity of lead exposure markers in diagnosis and surveillance. Clin Chem 1994;40:1387-90.
38. Church HJ, Day JP, Braithwaite RA, Brown SS. The speciation of lead in erythrocytes in relation to lead toxicity: case studies of two lead-exposed workers. Neurotoxicology 1993;14:359-64.
39. Goering PL, Fowler BA. Regulatory roles of high-affinity metal-binding proteins in mediating lead effects on delta-aminolevulinic acid dehydratase. Ann N Y Acad Sci 1987;514:235-47.
40. Fujita H, Orh Y, Sano S. Evidence of increased synthesis of & aminolevulinic acid dehydratase in experimental lead-poisoning. Biochim Biophys Acta 1981;678:39-50.
41. Rocha JB, Pereira ME, Emanuelli T, Christofari RS, Souza DO. Effect of treatment with mercury chloride and lead acetate during the second stage of rapid postnatal brain growth on delta-aminolevulinic acid dehydratase (ALA-D) activity in brain, liver, kidney and blood of suckling rats. Toxicology 1995;100:27-37.
42. Goering PL, Fowler BA. Mechanism of renal lead binding protein reversal of δ-aminolevulinic acid dehydratase inhibition by lead. J Pharmacol Exp Ther 1985;234:365-71.
43. Mistry P, Lucier GW, Fowler BA. High-affinity lead binding proteins in rat kidney cytosol mediate cell-free nuclear translocation of lead. J Pharmacol Exp Ther 1985;232:462-9.
44. Centers for Disease Control and Prevention (CDC). Blood lead levels- United States, 1999-2002. MMWR Morb Mortal Wkly Rep 2005;54:513-16.
45. Hansen JM, Zhang H, Jones DP. Differential oxidation of thioredoxin-1, thioredoxin-2, and glutathione by metal ions. Free Radic Biol Med 2006;40:138-45.
46. Reed DJ. Glutathione: toxicological implications. Annu Rev Pharmacol Toxicol 1990;30:603-31.
47. Söderberg A, Sahaf B, Rosén A. Thioredoxin reductase, a redox active selenoprotein, is secreted by normal and neoplastic cells: presence in human plasma. Cancer Res 2000;60:2281-9.
48. Jones CI, Zhu H, Martin SF, Han Z, Li Y, Alevriadou BR. Regulation of antioxidants and phase 2 enzymes by shear-induced reactive oxygen species in endothelial cells. Ann Biomed Eng 2007;35:683-93.
49. Lämsä V, Levonen AL, Leinonen H, Yla-Herttuala S, Yamamoto M, Hakkola J. Cytochrome P450 2A5 Constitutive expression and induction by heavy metals is dependent on redox-sensitive transcription factor Nrf2 in liver. Chem Res Toxicol 2010;23:977-85.
50. Park YS, Fujiwara N, Koh YH, Miyamoto Y, Suzuki K, Honke K et al. Induction of thioredoxin reductase gene expression by peroxynitrite in human umbilical vein endothelial cells. Biol Chem 2002;383:683-91.
51. Nishimoto M, Sakaue M, Hara S. Short-interfering RNA mediated silencing of thioredoxin reductase-1 alters the sensitivity of HeLa cells toward cadmium. Biol Pharm Bull 2006;29:543-6.
52. Chae HZ, Chung SJ, Rhee SG. Thioredoxin-dependent peroxide reductase from yeast. J Biol Chem 1994;269:27670-8.
53. Bjornstedt M, Hamberg M, Kumar S, Xue J, Holmgren A. Human thioredoxin reductase directly reduces lipid hydroperoxides by NADPH and selenocystine strongly stimulates the reaction via catalytically generated selenols. J Biol Chem 1995;270:11761-4.
54. Farmand F, Ehdaie A, Roberts CK, Sindhu RK. Lead-induced dysregulation of superoxide dismutases, catalase, glutathione peroxidase, and guanylate cyclase. Environ Res 2005;98:33-9.
55. Solliway BM, Schaffer A, Pratt H, Yannai S. Effects of exposure to lead on selected biochemical and haematological variables. Pharmacol Toxicol 1996;78:18-22.